Responses
Regular and young investigator award abstracts
Clinical trials in progress
354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
